Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 101.45 Bil Enterprise Value: 103.42 Bil PE Ratio: 23.72 PB Ratio: 3.57 GF Score: 86/100

Hologic Inc at UBS Global Healthcare Conference Transcript

May 20, 2019 / 12:00PM GMT
Daniel Gregory Brennan
UBS Investment Bank, Research Division - Senior Equity Research Analyst of Healthcare Life Sciences

Excellent. So thank you all for coming. This kicks off 2019 UBS Global Healthcare Conference. My name is Dan Brennan. I am the tools, diagnostics, pharma services analyst and I'm pleased to be joined on stage with me, Karleen Oberton, CFO of Hologic. Mike Watts is in here in the audience with us as well. Karleen is going to be hosting a breakout session in the Broadway Room following this presentation. Analyst disclaimer is on the screen. Please go to our website to see all disclosures. So we're going to have about 25 minutes. I have a series of questions obviously, but I'll break at some point to field any questions from the audience, so please don't be shy.

So maybe with that, Karleen, I thought maybe we could start -- well, first off, thank you for coming and welcome.

Karleen M. Oberton
Hologic, Inc. - CFO

Absolutely, thanks for having me.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot